NCT05743049Recruiting
Collection of Circulating Biomarkers in Pancreatic Cancer
Protocol to Permit Collection of Circulating Biomarkers in Pancreatic Cancer
Source: ClinicalTrials.gov · Last updated 7 Apr 2026
Brief summary (registry, in English)
This protocol will involve collection of blood samples from patients with a diagnosis of pancreatic adenocarcinoma for evaluation of circulating biomarkers.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 30 (estimated)
- First submitted
- 10 Feb 2023
- Start date
- 27 Feb 2023
- Primary completion date
- 30 Jun 2027
- Lead sponsor
- Abramson Cancer Center at Penn Medicine
- Diseases
- Pancreatic cancer
- NCT number
- NCT05743049
What you commit to
- Study type: Observational
- Planned participants: 30
- From 27 Feb 2023 to the primary completion date, 30 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- . Subjects who have any clinically significant psychiatric, social, or medical condition that, in the opinion of the investigator, could increase the patient's risk, interfere with protocol adherence, or affect the patient's ability to give informed consent are ineligible to participate in the study.
Who the study is looking for
- The subject must have a known or presumed diagnosis of pancreatic adenocarcinoma
- The subject must be a patient of the University of Pennsylvania
- The subject must be able to provide informed consent
- The subject must be 18 years of age or older
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Abramson Cancer Center at University of Pennsylvania Coordinator of this site? Confirm its status | Philadelphia | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.